25.4 Parasitic Infections of the Circulatory and Lymphatic Systems

Parasitic Infections of the Circulatory and Lymphatic Systems

Parasitic infections of the circulatory and lymphatic systems rank among the most significant global health challenges, particularly in tropical and subtropical regions. These infections involve complex life cycles that alternate between human hosts and arthropod or snail vectors, making them difficult to control and eradicate. This section covers the major parasites (malaria, toxoplasmosis, Chagas disease, leishmaniasis, and schistosomiasis), their life cycles, clinical presentations, treatments, and global prevention strategies.

Life Cycles of Circulatory Parasites

Malaria

Malaria is caused by Plasmodium species, which are protozoan parasites. Four species commonly infect humans: P. falciparum (the most deadly), P. vivax, P. ovale, and P. malariae. The parasite is transmitted through the bite of an infected female Anopheles mosquito, making it a vector-borne disease.

The life cycle alternates between the human host and the mosquito vector:

1. Infection: During a blood meal, the mosquito injects sporozoites into the human bloodstream. These travel to the liver.
2. Liver stage (exoerythrocytic cycle): Sporozoites invade liver cells (hepatocytes), multiply asexually, and release thousands of merozoites into the bloodstream. (P. vivax and P. ovale can form dormant hypnozoites in the liver, causing relapses months or years later.)
3. Blood stage (erythrocytic cycle): Merozoites infect red blood cells (RBCs), undergo further asexual reproduction, and cause RBC lysis upon release. This synchronized lysis is what produces the characteristic periodic fevers.
4. Gametocyte formation: Some merozoites differentiate into male and female gametocytes within RBCs.
5. Mosquito stage: A mosquito ingests gametocytes during a blood meal. Sexual reproduction occurs in the mosquito gut, ultimately producing new sporozoites that migrate to the salivary glands, completing the cycle.

Plasmodium parasites employ antigenic variation, constantly changing their surface proteins, which helps them evade the host immune response and makes vaccine development extremely challenging.

Toxoplasmosis

Toxoplasmosis is caused by Toxoplasma gondii, an obligate intracellular protozoan. Cats are the definitive host (where sexual reproduction occurs), while humans and other warm-blooded animals serve as intermediate hosts.

Transmission routes to humans:

• Ingestion of undercooked meat (especially pork and lamb) containing tissue cysts
• Ingestion of oocysts shed in cat feces, which contaminate soil, water, or food
• Vertical (transplacental) transmission from an infected mother to the fetus during pregnancy, causing congenital toxoplasmosis

Life cycle in humans:

1. Oocysts or tissue cysts are ingested and release sporozoites (from oocysts) or bradyzoites (from tissue cysts) in the small intestine.
2. These invade the intestinal epithelium and transform into rapidly dividing tachyzoites, the acute-phase form responsible for tissue damage.
3. Tachyzoites disseminate through the bloodstream to organs throughout the body.
4. As the immune response kicks in, tachyzoites convert to slow-growing bradyzoites, which form dormant tissue cysts in the brain, heart, and skeletal muscle. These cysts can persist for the life of the host.

Chagas Disease

Chagas disease is caused by Trypanosoma cruzi, a flagellated protozoan parasite. It is transmitted primarily by triatomine bugs (commonly called "kissing bugs") and is endemic to Latin America.

Life cycle:

1. The triatomine bug defecates while feeding on a human. Trypomastigotes in the bug's feces enter the body through the bite wound or mucous membranes (eyes, mouth). The parasite is not injected directly by the bite itself; the person typically rubs the contaminated feces into the wound or eyes.
2. Trypomastigotes invade host cells near the entry site and differentiate into amastigotes, the intracellular replicative form.
3. Amastigotes multiply by binary fission inside cells, then differentiate back into trypomastigotes.
4. When the host cell ruptures, trypomastigotes are released into the bloodstream, where they can infect new cells or be ingested by another triatomine bug during a blood meal, continuing the cycle.

Other transmission routes include blood transfusion, organ transplantation, and congenital transmission.

Symptoms and Treatment of Parasitic Diseases

Malaria

Symptoms result primarily from the erythrocytic cycle. Synchronized RBC lysis releases parasites and cellular debris, triggering:

• Periodic high fevers and chills (every 48 or 72 hours depending on species)
• Severe headache
• Anemia from RBC destruction
• Enlarged spleen (splenomegaly) as the spleen works to filter damaged RBCs

P. falciparum can cause severe complications including cerebral malaria, organ failure, and death.

Diagnosis:

• Microscopic examination of Giemsa-stained blood smears (the gold standard) to identify parasites and determine species
• Rapid diagnostic tests (RDTs) that detect parasite-specific antigens

Treatment:

• Artemisinin-based combination therapy (ACT) is the first-line treatment for P. falciparum malaria
• Chloroquine remains effective for P. vivax, P. ovale, and P. malariae in areas without chloroquine resistance
• Primaquine targets the hypnozoites of P. vivax and P. ovale in the liver to prevent relapse (patients must be tested for G6PD deficiency first, as primaquine can cause hemolytic anemia in deficient individuals)

Toxoplasmosis

Symptoms depend heavily on immune status:

• Immunocompetent individuals: Often asymptomatic or mild flu-like symptoms with swollen lymph nodes (lymphadenopathy). Most people never realize they're infected.
• Immunocompromised patients (e.g., HIV/AIDS): Reactivation of latent tissue cysts can cause life-threatening toxoplasmic encephalitis.
• Congenital toxoplasmosis: Can cause hydrocephalus, intracranial calcifications, and chorioretinitis (inflammation of the retina and choroid) in newborns. Severity depends on when during pregnancy infection occurs.

Diagnosis:

• Serology: Detection of IgM (acute infection) and IgG (past or chronic infection) antibodies
• PCR for parasite DNA in blood, amniotic fluid, or tissue
• Histopathology of tissue samples

Treatment:

• Combination of pyrimethamine and sulfadiazine (both target folate synthesis in the parasite) plus folinic acid to protect the patient's bone marrow
• Spiramycin is used during pregnancy to reduce the risk of transmission to the fetus

Chagas Disease

Symptoms occur in two distinct phases:

Acute phase (weeks to months after infection):

• Fever, fatigue, body aches
• Swelling at the inoculation site called a chagoma
• Romaña sign: Unilateral painless eyelid swelling, a classic finding when the parasite enters through the conjunctiva
• Many acute infections go unrecognized

Chronic phase (develops in ~30% of infected individuals years to decades later):

• Cardiomyopathy leading to heart failure, arrhythmias, and sudden death
• Megaesophagus: Dilated esophagus causing difficulty swallowing
• Megacolon: Enlarged colon causing severe constipation
• These result from progressive destruction of nerve cells (neurons of the autonomic nervous system) in affected organs

Diagnosis:

• Microscopic examination of blood smears (useful only in the acute phase when parasitemia is high)
• Serology to detect antibodies (primary method for chronic phase)
• PCR for parasite DNA

Treatment:

• Benznidazole or nifurtimox are the two available antiparasitic drugs
• Treatment is most effective during the acute phase; efficacy in the chronic phase is limited, and treatment of chronic Chagas remains an area of active research

Global Impacts of Tropical Diseases

Leishmaniasis

Leishmaniasis is caused by Leishmania species of protozoan parasites, transmitted by the bite of infected female phlebotomine sandflies. The disease takes several clinical forms: visceral leishmaniasis (kala-azar, the most severe, affecting internal organs), cutaneous leishmaniasis (skin ulcers, the most common form), and mucocutaneous leishmaniasis (destructive lesions of the nose, mouth, and throat).

Global impact: Endemic in 98 countries across 5 continents, with an estimated 1.3 million new cases annually and 20,000–30,000 deaths per year, mostly from visceral leishmaniasis.

Prevention strategies:

• Insecticide-treated bed nets (ITNs) and indoor residual spraying (IRS) to reduce sandfly populations
• Culling or treating infected dogs that serve as reservoir hosts for zoonotic Leishmania species
• Early diagnosis and prompt treatment of human cases to reduce the reservoir of infection

Schistosomiasis

Schistosomiasis is caused by trematode (fluke) parasites of the genus Schistosoma. The three major species infecting humans are S. mansoni, S. haematobium, and S. japonicum. Unlike the other parasites in this section, schistosomes are helminths (worms), not protozoans.

Transmission occurs through contact with freshwater containing cercariae, the free-swimming larval form released by infected freshwater snails (the intermediate host). Cercariae penetrate the skin directly during activities like wading, swimming, or washing.

Global impact: Over 240 million people are infected worldwide, predominantly in sub-Saharan Africa. The disease causes chronic inflammation and organ damage (liver fibrosis, bladder cancer with S. haematobium), resulting in significant morbidity and socioeconomic burden.

Prevention strategies aim to break the transmission cycle:

• Improved sanitation to prevent contamination of water sources with human waste containing parasite eggs
• Snail control using molluscicides to reduce intermediate host populations
• Mass drug administration (MDA) with praziquantel, which is effective against all Schistosoma species
• Health education programs promoting safe water practices and reducing contact with contaminated freshwater

Parasite-Host Interactions

These three concepts come up frequently when discussing circulatory and lymphatic parasitic infections:

• Parasitemia: The presence and quantity of parasites in the bloodstream. This term is used clinically to quantify infection intensity, particularly in malaria, where high parasitemia correlates with disease severity.
• Immunosuppression/Immune modulation: Many of these parasites actively suppress or redirect the host immune response to promote their own survival. For example, T. cruzi can downregulate certain immune pathways, and chronic Plasmodium infection impairs immune memory.
• Tissue tropism: The tendency of parasites to preferentially infect specific tissues or organs. This explains why different parasites cause different disease patterns: T. gondii forms cysts in the brain and muscle, T. cruzi targets cardiac and smooth muscle tissue, and Schistosoma species lodge in specific venous plexuses depending on species.